Lifeboat Foundation

Brain organoids are made from human pluripotent stem cells, which are cells that can become any kind of cell in the adult body. When the stem cells are introduced to certain chemicals, they can be coaxed into becoming brain cells, then put into a liquid with the nutrients they need to survive.

“The amazing thing is that, after this, they pretty much do everything alone,” says Alysson Muotri, a molecular biologist at UC San Diego. The cells self-assemble into spheres that contain neural progenitor cells, or cells that will become brain cells. Over the course of a few weeks, those cells turn into different kinds of neurons that can act just like neurons in the human brain.

In a study preprint published on bioRxiv and presented at the Society for Neuroscience conference last month, Muotri and his colleagues reported that they recorded spontaneous and complex electrical activity from their lab-grown mini brains. It’s the first time that brain organoids have spontaneously produced brain waves similar to human brain activity, Nature reported.

A wave of startups wants to make brain-computer interfaces accessible without needing surgery. Just strap on the device and think.

Researchers believe they have identified specific neurons that are responsible for conscious awareness. Previous studies have implicated both thalamocortical circuits and cortico-cortico circuits in consciousness. The new study reports these networks intersect via L5p neurons. Directly activating L5p neurons made mice react to weaker sensory stimuli. The researchers say if consciousness requires L5p neurons, all brain activity without them must be unconscious.

Researchers at Johns Hopkins Medicine have successfully used a laser-assisted imaging tool to “see” what happens in brain cells of mice learning to reach out and grab a pellet of food. Their experiments, they say, add to evidence that such motor-based learning can occur in multiple areas of the brain, even ones not typically associated with motor control.

“Scientists should be looking at the entire brain to understand specific types of learning,” says Richard Huganir, Ph.D., Bloomberg Distinguished Professor and Director of the Solomon H. Snyder Department of Neuroscience at the Johns Hopkins University School of Medicine. “Different parts of the brain contribute to learning in different ways, and studying brain cell receptors can help us decipher how this works.”

The work, say the researchers, may ultimately inform efforts to develop treatments for learning-based and neurocognitive disorders.

Scientists have uncovered a new kind of electrical process in the human brain that could play a key role in the unique way our brains compute.

Our brains are computers that work using a system of connected brain cells, called neurons, that exchange information using chemical and electric signals called action potentials. Researchers have discovered that certain cells in the human cortex, the outer layer of the brain, transmit signals in a way not seen in corresponding rodent cells. This process might be important to better understanding our unique brains and to improving programs that are based on a model of the human brain.

A newly published study has described the successful results in mice of a novel vaccine designed to prevent neurodegeneration associated with Alzheimer’s disease. The researchers suggest this “dementia vaccine” is now ready for human trials, and if successful could become the “breakthrough of the next decade.”

The new study, led by the Institute for Molecular Medicine and University of California, Irvine, describes the effect of a vaccine designed to generate antibodies that both prevent, and remove, the aggregation of amyloid and tau proteins in the brain. The accumulation of these two proteins is thought to be the primary pathological cause of neurodegeneration associated with Alzheimer’s disease.

The research revealed the vaccine led to significant decreases in both tau and amyloid accumulation in the brains of bigenic mice engineered to exhibit aggregations of these toxic proteins. Many prior failed Alzheimer’s treatments over the past few years have focused individually on either amyloid or tau protein reductions, but growing evidence suggests a synergistic relationship between the two toxic proteins may be driving neurodegeneration. Hence the hypothesis a combination therapy may be the most effective way to prevent this kind of dementia.

#13 in our top science stories of 2019.

https://youtube.com/watch?v=Tnr4EyTegcs

In his new book, The Deep History of Ourselves: The Four-Billion-Year Story of How We Got Our Conscious Brains, neuroscientist Joseph Ledoux assigns himself the simple tasks of explaining how consciousness developed and redefining how we create and experience emotions.

Obviously, I’m being facetious. There’s nothing simple about these tasks, yet in Ledoux’s capable hands the reader is led, step by step, through the past four billion years of life on this planet. Consciousness, a phenomenon responsible for your ability to read and understand these words (as well as much, much more), often feels like a given, yet that’s only because human life is short and evolution is so very long.

Continue reading “5 Important Features of Your Brain, According to a Top Neuroscientist” »

An international joint research team led by National Institute for Materials Science in Japan is currently developing a brain-like memory device using the neuromorphic network material.